About this episode

Dr. Raza Bokhari discusses Medicus Pharma's clinical programs and future plans for SkinJect and Teverelix.

This interview is disseminated on behalf of Medicus Pharma Ltd. With Phase 2 studies moving forward across its clinical programs, Medicus Pharma (NASDAQ: MDCX) is also planning to evaluate the use of its SkinJect anti-skin cancer patch to combat Gorlin Syndrome, a rare genetic disorder, as well as Teverelix for the potential treatment of endometriosis. Executive Chairman and CEO Dr. Raza Bokhari shares more details about the company’s FDA application to test SkinJect in Gorlin Syndrome patients, its genomics-enabled clinical trial in Abu Dhabi for Teverelix’s use in endometriosis, and anticipated growth milestones, including potential strategic partnerships. Learn more about Medicus Pharma: https://medicuspharma.com/ Watch the full YouTube interview here: https://youtu.be/v_ZhrQE2DFM And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

People in this episode

Guest: Dr. Raza Bokhari

Topics covered

• clinical trials
• skin cancer treatment
• genetic disorders
• endometriosis
• FDA application
• biotechnology

Keywords

• Medicus Pharma
• SkinJect
• Teverelix
• clinical trials
• Gorlin Syndrome
• endometriosis
• FDA application
• biotechnology

Mentioned in this episode

Organizations: Medicus Pharma Ltd.

Products: SkinJect, Teverelix

Places: Abu Dhabi, Gorlin Syndrome, endometriosis

More episodes of Stocks To Watch

• Episode 843: Disley Project Updates | Buffalo Potash ($BUFF | $BLPTF) CEO Interview · July 16, 2026 · 13 min
• Episode 842: Spartan Metals ($W | $SPRMF) is Advancing the Eagle and Victorio Tungsten Projects · July 13, 2026 · 11 min
• Episode 841: Elevate Service Group's ($SERV) Next Growth Phase & TFI Acquisition · July 7, 2026 · 8 min
• Episode 840: Allied Critical Metals ($ACM | $ACMIF) CEO on the Borralha Tungsten Project · July 7, 2026 · 9 min
• Episode 838: Toogood Gold ($TGC | $TGGCF): A New Nevada Gold Story Takes Shape · July 3, 2026 · 13 min
• Episode 837: Copper Fox Metals ($CUU | $CPFXF): Porphyry Copper Potential at the Mineral Mountain Project · July 3, 2026 · 11 min

Explore listener stats, chart rankings, contacts and more on the Stocks To Watch podcast page.